(Reuters) – Pfizer Inc is close to striking a deal with the U.S. government to supply at least tens of millions of additional doses of its COVID-19 vaccine candidate next year in exchange for a government directive giving it better access to manufacturing supplies, the New York Times reported on Tuesday.
An agreement could be announced as early as Wednesday, the newspaper reported https://www.nytimes.com/2020/12/22/us/pfizer-vaccine-trump-administration.html, citing people familiar with the discussions.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)
